Yescarta Market Report 2026
Download Free Sample Buy Now
Yescarta Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Yescarta Market Report 2026

Global Outlook – By Indication (Large B-Cell Lymphoma, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia, Follicular Lymphoma), By Distribution Channel (Hospitals, Specialty Clinics, Online Pharmacies), By End User (Adult, Geriatric) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Yescarta Market Overview

• The Yescarta market growth in the historic period has been driven by advances in genetic engineering technologies, increasing incidence of hematologic malignancies

• Market expansion is supported by expansion into additional cancer indications, rising investments in next-generation car constructs

• Growth Driver: Impact Of Rising Leukemia Incidence On The Market Growth

• North America was the largest region in 2025.

What Is Covered Under Yescarta Market?

Yescarta (axicabtagene ciloleucel) is a genetically engineered autologous T-cell therapy used for the treatment of certain types of hematologic cancers, specifically relapsed or refractory large B-cell lymphoma and primary mediastinal B-cell lymphoma in adults. It involves modifying a patient’s own T cells to express a chimeric antigen receptor (CAR) that targets CD19 on cancerous B cells.

The main indication for yescarta are large b-cell lymphoma, mantle cell lymphoma, acute lymphoblastic leukemia, follicular lymphoma. Large B-cell lymphoma (LBCL) is an aggressive type of non-Hodgkin lymphoma, a cancer that originates in the lymphatic system. These are distributed through various distribution channels such as hospitals, specialty clinics, online pharmacies and are used by various end users such as adult, geriatric.

Yescarta Market Global Report 2026 Market Report bar graph

What Is The Yescarta Market Size and Share 2026?

The growth in the historic period can be attributed to advances in genetic engineering technologies, increasing incidence of hematologic malignancies, regulatory approvals of car-t therapies, expansion of specialized cancer treatment centers, early success in refractory lymphoma treatment.

What Is The Yescarta Market Growth Forecast?

The growth in the forecast period can be attributed to expansion into additional cancer indications, rising investments in next-generation car constructs, growing focus on manufacturing scalability, increasing adoption in earlier treatment lines, development of cost-optimized cell therapy processes. Major trends in the forecast period include expanding adoption of car-t cell therapies in oncology, rising focus on personalized cancer treatments, growing investment in cell and gene therapy platforms, increased use of autologous immunotherapies, enhanced emphasis on long-term remission outcomes.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Yescarta Market Segmentation

1) By Indication: Large B-Cell Lymphoma, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia, Follicular Lymphoma

2) By Distribution Channel: Hospitals, Specialty Clinics, Online Pharmacies

3) By End User: Adult, Geriatric

What Are The Drivers Of The Yescarta Market?

The increasing incidence of leukemia is expected to propel the growth of the yescarta market going forward. Leukemia is a type of cancer that affects the blood and bone marrow, leading to the abnormal production of white blood cells. The increasing incidence of leukemia may be attributed to factors such as environmental exposures, genetic mutations, lifestyle changes, and improved detection methods. Yescarta, an advanced CAR T-cell therapy, revolutionizes leukemia treatment by reprogramming a patient’s own immune cells to target and destroy cancerous cells, offering renewed hope for improved outcomes in battling the disease. For instance, in 2024, according to the American Cancer Society, a US-based non-profit cancer advocacy organization, the number of leukemia cases increased to 62,770, reflecting an increase from 59,610 recorded in 2023. Therefore, the increasing incidence of leukemia drives the yescarta industry.

The rising demand for personalized medicine is expected to propel the growth of the Yescarta market going forward. Personalized medicine refers to a medical approach that tailors the prevention, diagnosis, and treatment of diseases to an individual’s unique genetic, environmental, and lifestyle factors. Rising demand for personalized medicine is primarily driven by the increasing prevalence of chronic and genetic diseases, which necessitates tailored treatments that improve patient outcomes and reduce adverse effects. Personalized medicine, driven by the increasing prevalence of chronic and genetic diseases, supports Yescarta by enabling targeted CAR-T therapies that are tailored to individual patients’ genetic and tumor profiles, thereby improving treatment efficacy and patient outcomes. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the rising demand for personalized medicine drives the Yescarta industry.

The growing number of clinical trials is expected to propel the growth of the Yescarta market going forward. Clinical trials refer to carefully designed research studies conducted with human participants to evaluate the safety, efficacy, and optimal use of new medical treatments, drugs, devices, or interventions before they are widely approved for general use. The growing number of clinical trials is primarily driven by the rising prevalence of chronic and rare diseases, as more patients require effective treatments, prompting pharmaceutical and biotech companies to develop and test new therapies to meet this increasing demand. Clinical trials help Yescarta by generating robust clinical evidence that demonstrates its safety and efficacy, supports regulatory approvals, and drives physician adoption and patient access. For instance, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, highlighted that the number of pharmaceutical industry trials launched in the UK increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Therefore, the growing number of clinical trials drives the Yescarta industry.

Key Players In The Global Yescarta Market

Major companies operating in the yescarta market are Kite Pharma Inc. ( a subsidiary of Gilead Sciences Inc.)

Need data on a specific region in this market?
Request Regional Data

Regional Insights

North America was the largest region in the yescarta market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Yescarta Market?

The yescarta market consists of sales of cell-based therapies and intravenous (IV) infusion. Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Yescarta Market Report 2026?

The yescarta market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the yescarta industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Yescarta Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Indication, Distribution Channel, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Kite Pharma Inc. ( a subsidiary of Gilead Sciences Inc.)
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Yescarta Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Yescarta Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Yescarta Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Yescarta Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics And Precision Medicine

4.1.2 Artificial Intelligence And Autonomous Intelligence

4.1.3 Industry 4.0 And Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data And Cybersecurity

4.1.5 Fintech, Blockchain, Regtech And Digital Finance

4.2. Major Trends

4.2.1 Expanding Adoption Of Car-T Cell Therapies In Oncology

4.2.2 Rising Focus On Personalized Cancer Treatments

4.2.3 Growing Investment In Cell And Gene Therapy Platforms

4.2.4 Increased Use Of Autologous Immunotherapies

4.2.5 Enhanced Emphasis On Long-Term Remission Outcomes

5. Yescarta Market Analysis Of End Use Industries

5.1 Oncology Hospitals

5.2 Specialty Cancer Centers

5.3 Hematology Clinics

5.4 Adult Patients

5.5 Geriatric Patients

6. Yescarta Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Yescarta Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Yescarta PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Yescarta Market Size, Comparisons And Growth Rate Analysis

7.3. Global Yescarta Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Yescarta Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Yescarta Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Yescarta Market Segmentation

9.1. Global Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Large B-Cell Lymphoma, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia, Follicular Lymphoma

9.2. Global Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Online Pharmacies

9.3. Global Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult, Geriatric

10. Yescarta Market Regional And Country Analysis

10.1. Global Yescarta Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Yescarta Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Yescarta Market

11.1. Asia-Pacific Yescarta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Yescarta Market

12.1. China Yescarta Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Yescarta Market

13.1. India Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Yescarta Market

14.1. Japan Yescarta Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Yescarta Market

15.1. Australia Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Yescarta Market

16.1. South Korea Yescarta Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Yescarta Market

17.1. Western Europe Yescarta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Yescarta Market

18.1. UK Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Yescarta Market

19.1. Germany Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Yescarta Market

20.1. France Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Yescarta Market

21.1. Eastern Europe Yescarta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Yescarta Market

22.1. North America Yescarta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Yescarta Market

23.1. USA Yescarta Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Yescarta Market

24.1. Canada Yescarta Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Yescarta Market

25.1. South America Yescarta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Yescarta Market

26.1. Middle East Yescarta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Yescarta Market

27.1. Africa Yescarta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Yescarta Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Yescarta Market Regulatory and Investment Landscape

29. Yescarta Market Competitive Landscape And Company Profiles

29.1. Yescarta Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Yescarta Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Yescarta Market Company Profiles

29.3.1. Kite Pharma Inc. (a subsidiary of Gilead Sciences Inc.) Overview, Products and Services, Strategy and Financial Analysis

30. Global Yescarta Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Yescarta Market

32. Yescarta Market High Potential Countries, Segments and Strategies

32.1 Yescarta Market In 2030 - Countries Offering Most New Opportunities

32.2 Yescarta Market In 2030 - Segments Offering Most New Opportunities

32.3 Yescarta Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Yescarta Market, Overview Of Key Products - Product Examples
  • Table 2: Global Yescarta Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Yescarta Market, Supply Chain Analysis
  • Table 4: Global Yescarta Market, Major Raw Material Providers
  • Table 5: Global Yescarta Market, Major Resource Providers
  • Table 6: Global Yescarta Market, Major Manufacturers (Suppliers)
  • Table 7: Global Yescarta Market, Major Distributors And Channel Partners
  • Table 8: Global Yescarta Market, Key Technologies & Future Trends
  • Table 9: Global Yescarta Market, Major Trends
  • Table 10: Global Yescarta Market, Major End Users
  • Table 11: Global Yescarta Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Yescarta Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Yescarta Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Yescarta Market - TAM, US$ Billion, 2025
  • Table 15: Global Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Yescarta Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Yescarta Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Asia-Pacific, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: China, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: India, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Japan, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Australia, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: South Korea, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Western Europe, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: UK, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Germany, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: France, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Eastern Europe, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: North America, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: USA, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Canada, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: South America, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Middle East, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Africa, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Global Yescarta Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 72: Global Yescarta Market - Company Scoring Matrix
  • Table 73: Kite Pharma Inc. (a subsidiary of Gilead Sciences Inc.) Financial Performance
  • Table 74: Global Yescarta Market, Competitive Benchmarking (In USD Billions)
  • Table 75: Global Yescarta Market, Competitive Dashboard
  • Table 76: Global Yescarta Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 77: Global, Yescarta Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 78: Global, Yescarta Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
  • Table 79: Global, Yescarta Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Yescarta Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Yescarta Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Yescarta Market, Supply Chain Analysis
  • Figure 4: Global Yescarta Market, Major Raw Material Providers
  • Figure 5: Global Yescarta Market, Major Resource Providers
  • Figure 6: Global Yescarta Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Yescarta Market, Major Distributors And Channel Partners
  • Figure 8: Global Yescarta Market, Key Technologies & Future Trends
  • Figure 9: Global Yescarta Market, Major Trends
  • Figure 10: Global Yescarta Market, Major End Users
  • Figure 11: Global Yescarta Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Yescarta Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Yescarta Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Yescarta Market - TAM, US$ Billion, 2025
  • Figure 15: Global Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Yescarta Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Yescarta Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Asia-Pacific, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: China, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: India, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Japan, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Australia, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: South Korea, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Western Europe, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: UK, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Germany, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: France, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Eastern Europe, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: North America, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: USA, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Canada, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: South America, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Middle East, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Africa, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Yescarta Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Global Yescarta Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 72: Global Yescarta Market - Company Scoring Matrix
  • Figure 73: Kite Pharma Inc. (a subsidiary of Gilead Sciences Inc.) Financial Performance
  • Figure 74: Global Yescarta Market, Competitive Benchmarking (In USD Billions)
  • Figure 75: Global Yescarta Market, Competitive Dashboard
  • Figure 76: Global Yescarta Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 77: Global, Yescarta Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 78: Global, Yescarta Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
  • Figure 79: Global, Yescarta Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Read More About Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Read More About Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Read More About Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Outlook for Generic Pharmaceuticals Contract Manufacturing Market: Key Developments and Future Strategies to 2029

Read More About Outlook for Generic Pharmaceuticals Contract Manufacturing Market: Key Developments and Future Strategies to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Chimeric Antigen Receptor T (CAR-T) Cells Global Market Report 2024 – By Target Antigen (CD19, CD22, Other Antigens), By Application (Acute Lymphoblastic Leukaemia, Diffuse Large B-Cell Lymphoma, Other Applications), By ...

Neoantigen Targeted Therapies Market Report 2026 - Global Outlook – By Type (Monotherapy, Combination Therapy), By Immunotherapy Type (DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based...

Prostate Specific Antigen (PSA) Test Market Report 2026 - Global Outlook – By Type (Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Type...

Cancer biologics Market Report 2026 - Global Outlook – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types ), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Mye...

Skin Cancer Drugs Market Report 2026 - Global Outlook – By Type (Actinic Keratoses (AK), Basal cell carcinoma (BCC), Squamous cell carcinoma (SCC), Melanoma ), By Drug Class (Chemotherapy, Immunotherapy, Targeted Agents ...

Pancreatic Cancer Drugs Market Report 2026 - Global Outlook – By Type (Pancreatic Neuroendocrine Cancer Drugs, Pancreatic Exocrine Cancer Drugs), By Drug Combination (Single, Double, Triplet, Quadruplet), By End User (Ho...

Breast Cancer Drugs Market Report 2026 - Global Outlook – By Type (Metastatic Breast Cancer, Triple Negative Breast Cancer, Other Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Othe...

Lung Cancer Drugs Market Report 2026 - Global Outlook – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs ), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung canc...

Frequently Asked Questions

The Yescarta market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Yescarta market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Yescarta market Include, Kite Pharma Inc. ( a subsidiary of Gilead Sciences Inc.) .

Major trend in this market includes: nan. For further insights on this market. request a sample here

North America was the largest region in the yescarta market in 2025. The regions covered in the yescarta market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us